University of California San Francisco
Give to UCSF
Displaying 9661 - 9690 of 16507
-
-
Students' Vision: To Support 'That Man May See'
-
Ombuds Works as a Neutral Party to Keep the Peace Across UCSF
<p>Randy Daron, PsyD, recently appointed UCSF Ombuds, finds himself frequently explaining the meaning of the word “Ombuds” to members of the UCSF community.</p>
-
San Francisco's Torch Song Still Burns Brightly
-
Vegas Gala to Celebrate Muhammad Ali's 70th Birthday, Benefit Ruvo Center
-
Study Weighs Pros, Cons of Home or Hospital Birth
-
Dean Ornish Talks Lifestyle As Treatment At NYC's Integrative Healthcare Symposium
-
Obama's Birth-Control Rule Will Help Prevent Accidental Pregnancies
-
Mad-Cow Disease Unlikely in Marin Cases
-
Tenofovir: Q&A for Patients and Providers
<p>Scientists at the San Francisco VA Medical Center and the University of California, San Francisco have published a study showing that one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, tenofovir, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time. See accompanying news release, <a href="http://ucsf.edu/news/2012/02/11508/tenofovir-leading-hiv-medication-linked-risk-kidney-damage">Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage</a>.</p>
-
Media Advisory: Black History Month Conference
<p>The Second Annual Florence Stroud Black History Month Conference Series presents a special symposium, "<em>Joining Forces: Answering the Call to Serve Military Families.</em>'' The event will focus on the myriad challenges facing members of the military and their families, including post-traumatic stress disorder, suicide, and other psychological issues.</p>
-
Tony Bennett to Be Honored at SF City Hall
-
Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and UCSF.
-
California Sets Trends in Health Regulation
-
Norwegian Lundehunds Bring New Life, Love to Owner
-
Midwives Make Home Births Safer for Babies
-
SF Songfest, "I Left My Heart in San Francisco" with Tony Bennett on February 14
-
Ron Conway is a Silicon Valley Startup's Best Friend
-
Pediatric Dentist Applies Science to Prevent Cavities
<p>Pediatric dentist Ling Zhan, an assistant professor in the UCSF School of Dentistry, is working to better understand the risk factors for cavities, and balance these with proven prevention measures, which has proven to be successful by adults.</p>
-
UCSF Still May Do Jesus Navarro Kidney Transplant
-
Last Patients on ICU Rounds Get Least Time
-
Marin County Probes 2 Cases of Rare Brain Disease
-
Could Babies Born Today Live to 150?
-
UCSF Issues Joint Statement From Kidney Transplant Candidate and Chief Medical Officer
<p>UCSF is committed to helping kidney transplant candidate Jesus Navarro, who remains on the waiting list, according to a joint statement released by him and Chief Medical Officer Joshua Adler, MD.</p>
-
Gauging Hype During Heart Month: 5 Tests You Might Not Need
-
How a Cold Blanket Can Save a Newborn's Life
-
Chancellor Names "Future of UCSF" Working Group Members
<p>UCSF Chancellor Susan Desmond-Hellmann today named members of the “Future of UCSF" working group, charged with exploring changes to UCSF’s current governance structure and financial relationship with the UC system.</p>
-
Who's Who in the "Future of UCSF" Working Group
<p>UCSF Chancellor Susan Desmond-Hellmann named a working group consisting of 13 leaders from UC, UCSF and business who have agreed to take on the critically important assignment of exploring a new business model for the health sciences university.</p>
-
David Saloner Elected to Elite Medical and Biological Engineering College of Fellows
<p>UCSF's David Saloner, PhD, was elected by his peers to the American Institute for Medical and Biological Engineering College of Fellows for his outstanding contributions to advancing the quantitative imaging of vascular and cardiac biomechanics and function.</p>
-
17-Year-Old Devises Potential Cure for Cancer